Filter
551
Text search:
médicaments
Featured
42
168
Language
Document type
298
102
67
19
17
16
9
7
6
6
2
2
Countries / Regions
32
24
23
22
22
21
20
20
18
17
15
15
15
14
13
13
12
12
12
12
12
11
10
9
9
9
7
7
6
6
6
6
6
6
5
5
5
4
4
4
4
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
478
13
11
4
3
3
2
Toolboxes
86
30
22
11
8
7
4
3
3
3
3
3
3
2
1
1
Decree of the Minister of Health of the Republic of Indonesia on the Establishment of Hospitals and Satellite Test of Methadone Therapy Service and Program Guidelines for Methadone Maintenance Therapy
Decree of the Minister of Health of the Republic of Indonesia Number 1190 / MENKES / SK / X / 2004 on the Free Drug of Anti Tuberculosis (OAT) and Anti Retro Viral (ARV) Drugs for HIV / AIDS
Law of the Republic of Indonesia on Narcotics
Regulation of the Minister of Health of the Republic of Indonesia on Impact Reduction for Injecting Narcotics Drug Users
NAPZA : Narkotika, Psikotropika dan Zat Adiktif Lainnya (Narcotics, Psychotropic and Other Addictive Substances)
Regulation of the Minister of Health of the Republic of Indonesia on Guidelines for Antiretroviral Treatment
Regulation of the President of the Republic of Indonesia on the Implementation of Patents by the Government on Antiviral and Antiretroviral Drugs
National Policy on HIV and AIDS Response through Reduction of Adverse Effects of the Usage of Injecting Narcotics, Psychotropics and other addictive Substances
Government Regulation of the Republic of Indonesia regarding Security of Pharmaceutical Preparations and Medical Equipments
Accessed August 31,2017
Accessed August, 2017
Drug Advisory Board
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
